Published in

Springer, PharmacoEconomics, 8(40), p. 791-806, 2022

DOI: 10.1007/s40273-022-01152-8

Links

Tools

Export citation

Search in Google Scholar

Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease

Journal article published in 2022 by Katya Galactionova, Paola Salari ORCID, Renato Mattli, Yael Rachamin, Rahel Meier, Matthias Schwenkglenks ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO